血浆治疗市场规模、份额和增长分析（按类型、来源、应用、最终用户和地区）- 产业预测 2025-2032

2023 年全球血浆治疗市场规模价值为 3.1 亿美元，预计将从 2024 年的 3.5433 亿美元增长到 2032 年的 10.3223 亿美元，预计在预测期内（2025-2032 年）到 2032 年将达到 1 亿美元)预计将以14.3%的复合年增长率成长。

由于男性脱髮症和运动相关伤害的增加，血浆治疗市场预计将成长。由于血浆具有高浓度的抗体，其治疗用途可提供免疫转移，并且在整形外科、皮肤科和牙科方面特别有益。富血小板血浆 (PRP) 在各个治疗领域的应用日益广泛，也成为主要的成长催化剂。然而，缺乏报销框架、与血浆疗法相关的各种费用以及糖尿病和肾衰竭患者的疗效有限等挑战可能会阻碍市场扩张。此外，关节炎病例的急剧增加可能会减缓增长。总体而言，不断增长的患者需求和新的治疗应用的融合为该领域的相关人员提供了重要的未来机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究分析

血浆治疗市场规模（按类型）

• 市场概况
• 纯 PRP
• 富含白血球的 PRP
• 纯血小板中富含纤维蛋白
• 富含纤维蛋白的白血球

血浆治疗市场规模（依供应来源）

• 市场概况
• 家
• 同一物种

血浆治疗市场规模（按应用）

• 市场概况
• 整形外科
  • 关节炎
  • 慢性肌腱炎
  • 骨修復和再生
• 皮肤科
  • 男性脱髮症
  • 整形外科
• 心肌损伤
• 牙科
• 神经损伤
• 其他的

血浆治疗市场规模（按最终用户划分）

• 市场概况
• 医院和诊所
• 研究组织

血浆治疗市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• CSL Behring（Australia）
• Grifols SA（Spain）
• Kedrion SpA（Italy）
• Octapharma AG（Switzerland）
• Takeda Pharmaceutical Company Limited（Japan）
• Zimmer Biomet（US）
• Baxter International Inc.（US）
• China Biologic Products Holdings, Inc.（China）
• GC Pharma（South Korea）
• Green Cross Corp.（South Korea）
• Japan Blood Products Organization（Japan）
• LFB SA（France）
• Shanghai RAAS Blood Products Co., Ltd.（China）
• China National Biotec Group Co., Ltd.（CNBG）（China）
• Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.（China）
• Jiangxi Boya Bio-Pharmaceutical Co., Ltd.（China）
• Bio Products Laboratory Ltd.（BPL）（UK）
• BioLife Plasma Services（US）
• Canadian Plasma Resources（Canada）

结论和建议

Global Plasma Therapy Market size was valued at USD 310.0 million in 2023 and is poised to grow from USD 354.33 million in 2024 to USD 1032.23 million by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

The market for plasma therapy is poised for growth, driven by the increasing incidence of androgenic alopecia and sports-related injuries. With plasma's high antibody concentration, its therapeutic application offers immunity transfer, particularly beneficial in orthopaedics, dermatology, and dentistry. The rising adoption of platelet-rich plasma (PRP) across various therapeutic areas is also a significant growth catalyst. However, challenges such as the lack of reimbursement frameworks, varied costs associated with plasma therapy, and limited efficacy in diabetic and kidney-compromised patients may hinder market expansion. Additionally, the surge in arthritis cases could moderate growth. Overall, the convergence of increasing patient demand and emerging treatment applications presents substantial future opportunities for stakeholders in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Plasma Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Plasma Therapy Market Segmental Analysis

Global Plasma Therapy Market is segmented by Type, Source, Application, End User and region. Based on Type, the market is segmented into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin. Based on Source, the market is segmented into Autologous and Allogenic. Based on Application, the market is segmented into Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. Based on End User, the market is segmented into Hospitals & Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Plasma Therapy Market

The Global Plasma Therapy market is experiencing significant growth due to several driving factors. A notable increase in the use of platelet-rich plasma (PRP) is attributed to a surge in sports injuries, along with a rising demand for cosmetic procedures, as more individuals engage in athletic activities. Additionally, the expanded application of PRP in research is further propelling the sector forward. As awareness of the benefits of plasma therapy continues to grow, fueled by its effectiveness in healing and rejuvenation, the market is well-positioned for continued expansion, attracting both medical professionals and patients alike.

Restraints in the Global Plasma Therapy Market

The Global Plasma Therapy market faces significant restraints primarily due to the high costs associated with the treatment. The expenses involved in extracting plasma from blood and the subsequent storage requirements pose a challenge to market growth. In both developing and underdeveloped regions, these costs have greatly limited the accessibility and utilization of plasma therapy. As a result, the average individual often finds the treatment financially out of reach, which serves as a major barrier to market expansion. Consequently, the high financial burden associated with plasma therapy remains one of the primary factors hindering its wider adoption and development.

Market Trends of the Global Plasma Therapy Market

The global plasma therapy market is poised for significant growth driven by an increasing prevalence of androgenic alopecia and orthopedic disorders. As healthcare advancements expand treatment options, consumers are now empowered to select therapies aligned with their financial capabilities, thus enhancing market accessibility. Nevertheless, challenges persist, notably the limited application of platelet-rich plasma (PRP) in patients with diabetes and kidney issues, which may hinder market expansion. Additionally, the rise of innovative healthcare technologies is improving treatment efficacy, particularly for rare diseases, fostering increased interest in plasma therapies. Overall, these trends indicate a dynamic future landscape for the plasma therapy market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Plasma Therapy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pure PRP
• Leukocyte-Rich PRP
• Pure Platelet-Rich Fibrin
• Leukocyte-Rich Fibrin

Global Plasma Therapy Market Size by Source & CAGR (2025-2032)

• Market Overview
• Autologous
• Allogenic

Global Plasma Therapy Market Size by Application & CAGR (2025-2032)

• Market Overview
• Orthopedic
  • Arthritis
  • Chronic Tendinitis
  • Bone Repair & Regeneration
• Dermatology
  • Androgenic Alopecia
  • Plastic Surgery
• Cardiac Muscle Injury
• Dental
• Nerve Injury
• Others

Global Plasma Therapy Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Research Institutes

Global Plasma Therapy Market Size & CAGR (2025-2032)

• North America (Type, Source, Application, End User)
  • US
  • Canada
• Europe (Type, Source, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Source, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Source, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Source, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CSL Behring (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GC Pharma (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Green Cross Corp. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Blood Products Organization (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China National Biotec Group Co., Ltd. (CNBG) (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangxi Boya Bio-Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (BPL) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Plasma Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canadian Plasma Resources (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations